These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 1713406

  • 1. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors.
    Conn M, Goldenberg A, Concepcion L, Mandeli J.
    Am J Gastroenterol; 1991 Aug; 86(8):1011-4. PubMed ID: 1713406
    [Abstract] [Full Text] [Related]

  • 2. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage.
    Hardt PD, Fadgyas T, Kress O, Doppl WE, Weber HP, Bimler EA, Temme H, Klör HU.
    Z Gastroenterol; 1999 Aug; 37(8):701-5. PubMed ID: 10494604
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of ERCP- and endoscopic sphincterotomy-induced pancreatic damage: a prospective study on the time course and the significance of serum levels of pancreatic secretory enzymes.
    Doppl WE, Weber HP, Temme H, Klör HU, Federlin K.
    Eur J Med Res; 1996 Mar 19; 1(6):303-11. PubMed ID: 9367944
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
    Kapetanos D, Kokozidis G, Kinigopoulou P, Xiarchos P, Antonopoulos Z, Progia E, Kitis G.
    Hepatogastroenterology; 2007 Mar 19; 54(74):556-60. PubMed ID: 17523321
    [Abstract] [Full Text] [Related]

  • 6. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V.
    N Engl J Med; 1996 Sep 26; 335(13):919-23. PubMed ID: 8786777
    [Abstract] [Full Text] [Related]

  • 7. Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis.
    Mann DV, Kalu P, Foulds S, Edwards R, Glazer G.
    Endoscopy; 2001 May 26; 33(5):448-53. PubMed ID: 11396766
    [Abstract] [Full Text] [Related]

  • 8. Early sequential changes in serum markers of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography.
    Lempinen M, Stenman UH, Halttunen J, Puolakkainen P, Haapiainen R, Kemppainen E.
    Pancreatology; 2005 May 26; 5(2-3):157-64. PubMed ID: 15849486
    [Abstract] [Full Text] [Related]

  • 9. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
    Buscaglia JM, Simons BW, Prosser BJ, Ruben DS, Giday SA, Magno P, Clarke JO, Shin EJ, Kalloo AN, Kantsevoy SV, Gabrielson KL, Jagannath SB.
    JOP; 2008 Jul 10; 9(4):456-67. PubMed ID: 18648137
    [Abstract] [Full Text] [Related]

  • 10. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M, Supanc V, Simicević VN, Hrabar D, Troskot B, Smircić-Duvnjak L, Bekavac-Beslin M.
    Acta Med Croatica; 1999 Jul 10; 53(3):115-8. PubMed ID: 10705631
    [Abstract] [Full Text] [Related]

  • 11. Changes in serum levels of pancreatic isoamylase, lipase, trypsin, and elastase 1 after endoscopic retrograde pancreatography.
    Okuno M, Himeno S, Kurokawa M, Shinomura Y, Kuroshima T, Kanayama S, Tsuji K, Higashimoto Y, Tarui S.
    Hepatogastroenterology; 1985 Apr 10; 32(2):87-90. PubMed ID: 3847383
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D, Hatzipanayiotis J, Koutsounopoulos G, Frangou E.
    Hepatogastroenterology; 1998 Apr 10; 45(19):248-52. PubMed ID: 9496522
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma alpha 2-macroglobulin-trypsin complexlike substance (MTLS) in pancreatic disease.
    Kato M, Hayakawa S, Naruse S, Kitagawa M, Nakae Y, Hayakawa T.
    J Clin Lab Anal; 1996 Apr 10; 10(6):399-402. PubMed ID: 8951609
    [Abstract] [Full Text] [Related]

  • 19. Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy.
    Kemppainen E, Hedström J, Puolakkainen P, Halttunen J, Sainio V, Haapiainen R, Kivilaakso E, Stenman UH.
    Gut; 1997 Nov 10; 41(5):690-5. PubMed ID: 9414980
    [Abstract] [Full Text] [Related]

  • 20. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting.
    Pan XP, Dang T, Meng XM, Xue KC, Chang ZH, Zhang YP.
    Cell Biochem Biophys; 2011 Dec 10; 61(3):473-9. PubMed ID: 21739262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.